Cosmos Study October 14, 2025 Dual-Team Study Team A:Kersten Bartelt, RNEric Barkley Team B:Joel Jones, PharmDJoe Deckert, PhD Key Findings Among non-diabetic patients without chronic kidney disease (CKD), there was a minimal increase of 0.01 mg/dL to 0.02 mg/dL in serum creatinine in the months following initiation of semaglutide, liraglutide, or tirzepatide
Serious adverse effects are uncommon but possible, including allergic reactions, severe injection site reactions if improper technique is used, and excessive detoxification responses in susceptible individuals
Islet distribution of Peptide YY and its regulatory role in primary mouse islets and immortalised rodent and human beta-cell function and survival
Scientific Opinion on the Safety of Conjugated Linoleic Acid (CLA)-Rich Oil (Tonalin TG 80) as a Novel Food Ingredient. EFSA Journal 8 (5): 1600-43
No other potential competing interests relevant to this article are reported
Three sub-points decide whether any of it helps you